Related Experiment Video
Updated: Aug 7, 2026
06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Aortic arch vessel stenting: a single-center experience using cerebral protection
Brian G Peterson1, Scott A Resnick, Mark D Morasch
1Division of Vascular Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill, USA.
Archives of Surgery (Chicago, Ill. : 1960)
|June 21, 2006
Summary
Endovascular stenting of brachiocephalic arteries is a safe and effective treatment for stenosis, offering a less invasive alternative to open surgery. This study found no deaths, strokes, or restenosis in patients undergoing the procedure.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Interventions
Background:
- Traditional surgical bypass for supra-aortic trunk disease involves significant morbidity.
- Endovascular therapy presents a potentially less invasive treatment option.
Purpose of the Study:
- To evaluate the safety and efficacy of endoluminal stenting for brachiocephalic arch vessel stenoses.
- To compare outcomes with traditional surgical approaches.
Main Methods:
- Retrospective review of 20 brachiocephalic-origin stenoses treated with balloon-expandable stents.
- Procedures performed in an operating room angiosuite.
- Cerebral protection utilized distal embolic filters or surgical occlusion.
Main Results:
- 18 patients (mean age 68) with 20 stenoses (mean 85% stenosis) were treated.
- 80% of patients presented with symptoms like stroke or transient ischemic attack.
- No deaths, myocardial infarctions, or strokes occurred within 30 days.
- No restenosis was observed during a mean follow-up of 12 months.
Conclusions:
- Endoluminal arterial stenting is a viable alternative for focal stenotic disease in brachiocephalic arch vessels.
- The procedure demonstrates favorable immediate and midterm outcomes.